Werner Liliana, Pandey Suresh K, Izak Andrea M, Hickman M Scott, LeBoyer Russell M, Mamalis Nick
John A. Moran Eye Center, University of Utah, Salt Lake City, Utah 84132, USA.
J Cataract Refract Surg. 2005 Jul;31(7):1414-20. doi: 10.1016/j.jcrs.2004.10.071.
To evaluate the toxicity and cataractogenic effect of solutions combining sodium (Na) hyaluronate 1.0% and 1.5% with lidocaine 1.0% on the rabbit crystalline lens. The amount of pupil dilation provided by the addition of lidocaine to the Na hyaluronate solutions was also assessed.
John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Five solutions were injected into the anterior chamber of 18 pigmented rabbits in a randomized manner by the same surgeon, the intraocular component of VisThesia (Na hyaluronate 1.5%/lidocaine 1.0%), the intraocular component of VisThesia Light (Na hyaluronate 1.0%/lidocaine 1.0%), Ophthalin Plus (Na hyaluronate 1.5%), and a balanced salt solution; and both eyes of 2 other rabbits were injected with nonpreserved aqueous lidocaine 1.0%. The pupil diameter of each eye was measured before injection, immediately after, and 1 and 5 minutes after injection. After a follow-up of 3 months with slitlamp examinations, the rabbits were killed, and their eyes were enucleated. The crystalline lenses were evaluated from a posterior or Miyake-Apple view, and the eyes were fixated in 10% formalin for histopathologic analyses.
Pupil diameter was significantly larger 1 and 5 minutes after injection in the VisThesia (P = .01 and P = .007) and VisThesia Light (P = .008 and P = .007) groups, whereas the differences were not significant in the Ophthalin Plus (P = .317 and P = .102) and balanced salt solution groups (P = .317 and P = .180). Fast and large pupillary dilation was observed in the aqueous lidocaine group, starting during the injection. No differences in the transparency of the natural lens and the red fundus reflex were noted during slitlamp examinations. Postmortem analyses from a posterior view also showed no differences in the transparency of the crystalline lens. The histopathologic appearance of the lens capsule, anterior and equatorial lens epithelial cells, and epithelial lens bow was comparable in the eyes, without signs of cell vacuolization or disruption.
Intracameral injection of the solutions used in this study caused no localized opacity or overall change in the transparency of the crystalline lenses as observed during clinical and postmortem examinations as well as histopathologic analyses of the enucleated rabbit eyes. Viscoanesthesia may have application in phakic intraocular lens implantation.
评估1.0%和1.5%的透明质酸钠溶液与1.0%利多卡因混合溶液对兔晶状体的毒性和致白内障作用。还评估了在透明质酸钠溶液中添加利多卡因后的瞳孔散大程度。
美国犹他州盐湖城犹他大学约翰·A·莫兰眼科中心。
由同一位外科医生以随机方式将五种溶液注入18只色素兔的前房,分别是VisThesia的眼内成分(1.5%透明质酸钠/1.0%利多卡因)、VisThesia Light的眼内成分(1.0%透明质酸钠/1.0%利多卡因)、Ophthalin Plus(1.5%透明质酸钠)和平衡盐溶液;另外2只兔的双眼注射1.0%的无防腐剂水性利多卡因。在注射前、注射后即刻以及注射后1分钟和5分钟测量每只眼睛的瞳孔直径。在裂隙灯检查随访3个月后,处死兔子并摘除眼球。从后极或Miyake-Apple视图评估晶状体,并将眼球固定在10%福尔马林中进行组织病理学分析。
VisThesia组(P = 0.01和P = 0.007)和VisThesia Light组(P = 0.008和P = 0.007)在注射后1分钟和5分钟时瞳孔直径显著更大,而Ophthalin Plus组(P = 0.317和P = 0.102)和平衡盐溶液组(P = 0.317和P = 0.180)差异不显著。在水性利多卡因组中,在注射过程中就开始观察到快速且较大的瞳孔散大。在裂隙灯检查期间,未观察到天然晶状体透明度和眼底红光反射的差异。死后从后极视图分析也显示晶状体透明度无差异。眼中晶状体囊膜、前极和赤道部晶状体上皮细胞以及晶状体上皮弓的组织病理学外观相当,没有细胞空泡化或破坏的迹象。
本研究中使用的溶液前房内注射,在临床和死后检查以及摘除的兔眼组织病理学分析中,未观察到晶状体局部混浊或透明度的总体变化。黏弹麻醉可能在有晶状体眼人工晶状体植入术中具有应用价值。